FIELD: pharmacy.
SUBSTANCE: invention relates to novel crystalline water-soluble salts of (2S,3S)-enantiomer of 2-[α-(2-ethoxyphenyl)benzyl]-morpholine that are its fumarate and succinate salts. Also, invention relates to a method for their preparing and their using in preparing pharmaceutical composition possessing property of selective inhibitor of reverse uptake of norepinephrine, and to a pharmaceutical composition comprising thereof.
EFFECT: improved and valuable properties of drug.
7 cl, 6 tbl, 5 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OBTAINING ARYL ETHERS | 2005 |
|
RU2330012C2 |
| POLYMORPHIC FORMS | 2014 |
|
RU2670978C9 |
| SUBSTITUTED DERIVATIVES OF BISPHENYL ESTER OF BUTYRIC ACID AS NEP INHIBITORS | 2019 |
|
RU2784522C2 |
| SULPHATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOLE-2-AMINE, PREPARATION THEREOF AND USE OF SAME | 2013 |
|
RU2655454C2 |
| SALTS AND CRYSTALLINE FORMS | 2014 |
|
RU2654855C2 |
| NONHYGROSCOPIC CRYSTALLINE 5-[(Z)-(5-FLUORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[(2S)-2-HYDROXY-3-MORPHOLIN-4-YLPROPYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALEATE SALT, PHARMACEUTICAL COMPOSITION AND METHOD FOR CANCER TREATMENT | 2004 |
|
RU2319702C2 |
| SEPARATION OF OPTICAL ISOMERS OF 2-(DIPHENYLMETHYL)-3-(2-METHOXY-5- ISOPROPYLPHENYL)METHIAMINO-1-AZABICYCLO-[2,2,2]-OCTANE | 1996 |
|
RU2136681C1 |
| METHOD FOR PRODUCING OPTICALLY ACTIVE ENANTIOMERS OF PIRLINDOLE AND ITS SALTS | 2014 |
|
RU2666731C2 |
| COMBINATIONS CONTAINING ALPHA-2-DELTA LIGANDS AND SEROTONIN/NORADRENALINE REUPTAKE INHIBITORS | 2004 |
|
RU2320369C2 |
| CRYSTALLINE FUMARATE SALT OF (S)-[3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)PHENYL][3-HYDROXY-3-(PIPERIDINE-2-YL)AZETIDINE-1-YL]METHANONE | 2016 |
|
RU2762181C2 |
